2020 Annual Meeting | C29 - Critical Care Consultations for Neurohospitalists

Date Saturday 04/25/20

Time 01:30 PM - 03:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Vanja C. Douglas, MD, FAAN

Topic(s) General Neurology, Neuro Trauma, Critical Care, and Sports Neurology

Learning Objectives Participants should be able to discuss the neuroprotective effect of targeted temperature management after cardiac arrest and prognosticate effectively in these patients; use the most up-to-date treatment algorithms for status epilepticus and describe approaches to treatment of non-convulsive status epilepticus; and diagnose both the most common causes of neuromuscular respiratory failure, as well as rare but treatable diseases.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider, Neurohospitalist

Recommended Audience General Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic

Event Timeline
01:30 PM - 01:35 PM	Introduction	Introduction Vanja C. Douglas, MD, FAAN
01:35 PM - 02:10 PM	Speaker	Status Epilepticus John Betjemann, MD
02:10 PM - 02:45 PM	Speaker	Neuromuscular Respiratory Failure Bob Bucelli, MD, PhD
02:45 PM - 03:20 PM	Speaker	Neuroprotection and Prognosis After Cardiac Arrest in the Era of Therapeutic Hypothermia Vanja C. Douglas, MD, FAAN
03:20 PM - 03:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Vanja C. Douglas, MD, FAAN	Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
John Betjemann, MD	No disclosure on file
Bob Bucelli, MD, PhD	Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.

��ɫ��

��ɫ��